Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.

Morgese, Maria Grazia

Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. [electronic resource] - Experimental neurology Nov 2007 - 110-9 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

0014-4886

10.1016/j.expneurol.2007.07.021 doi


Amidohydrolases--antagonists & inhibitors
Animals
Antiparkinson Agents--adverse effects
Arachidonic Acids--metabolism
Basal Ganglia--metabolism
Benzamides--therapeutic use
Benzoxazines--therapeutic use
Cannabinoids--agonists
Capsaicin--analogs & derivatives
Carbamates--therapeutic use
Drug Therapy, Combination
Dyskinesia, Drug-Induced--metabolism
Endocannabinoids
Levodopa--adverse effects
Male
Morpholines--therapeutic use
Naphthalenes--therapeutic use
Oxidopamine
Parkinson Disease, Secondary--chemically induced
Polyunsaturated Alkamides--metabolism
Rats
Rats, Wistar
Receptor, Cannabinoid, CB1--drug effects
TRPV Cation Channels--antagonists & inhibitors